TREVOR HARVEY: Open Payments
NPI 1174132948 · HARRISONVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 43 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $34 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $96 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Novo Nordisk Inc | 3 | $58 |
| PFIZER INC. | 2 | $51 |
| Dexcom, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Lilly USA, LLC | 2 | $33 |
Products named: REXULTI, CAPLYTA, Ozempic, AIRSUPRA, Dexcom G6 Transmitter, HETLIOZ, CREON, LEQVIO.
Industry payments across MO — which companies pay providers there.
